These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33957930)

  • 61. Review article: the management of primary sclerosing cholangitis.
    Mitchell SA; Chapman RW
    Aliment Pharmacol Ther; 1997 Feb; 11(1):33-43. PubMed ID: 9042972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease.
    Delladetsima J; Alexandrou P; Giaslakiotis K; Psichogiou M; Hatzis G; Sypsa V; Tiniakos D
    Virchows Arch; 2010 Oct; 457(4):457-66. PubMed ID: 20721577
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
    Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
    Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Small-duct primary sclerosing cholangitis: a long-term follow-up study.
    Angulo P; Maor-Kendler Y; Lindor KD
    Hepatology; 2002 Jun; 35(6):1494-500. PubMed ID: 12029635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score.
    Khoshpouri P; Ameli S; Ghasabeh MA; Pandey A; Zarghampour M; Varzaneh FN; Jacob A; Pandey P; Luo Y; Kamel IR
    Eur J Radiol; 2018 Nov; 108():254-260. PubMed ID: 30396665
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The evolution of natural history of primary sclerosing cholangitis.
    Takakura WR; Tabibian JH; Bowlus CL
    Curr Opin Gastroenterol; 2017 Mar; 33(2):71-77. PubMed ID: 28030370
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease.
    Sheng R; Campbell WL; Zajko AB; Baron RL
    AJR Am J Roentgenol; 1996 May; 166(5):1109-13. PubMed ID: 8615253
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does transient elastography correlate with liver fibrosis in patients with PSC? Laennec score-based analysis of explanted livers.
    Krawczyk M; Ligocka J; Ligocki M; Raszeja-Wyszomirska J; Milkiewicz M; Szparecki G; Ilczuk T; Górnicka B; Zieniewicz K; Krawczyk M; Lammert F; Milkiewicz P
    Scand J Gastroenterol; 2017 Dec; 52(12):1407-1412. PubMed ID: 28851259
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The ascending pathophysiology of cholestatic liver disease.
    Jansen PL; Ghallab A; Vartak N; Reif R; Schaap FG; Hampe J; Hengstler JG
    Hepatology; 2017 Feb; 65(2):722-738. PubMed ID: 27981592
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.
    Eaton JE; Vesterhus M; McCauley BM; Atkinson EJ; Schlicht EM; Juran BD; Gossard AA; LaRusso NF; Gores GJ; Karlsen TH; Lazaridis KN
    Hepatology; 2020 Jan; 71(1):214-224. PubMed ID: 29742811
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [MRCP in primary sclerosing cholangitis].
    Weber C; Krupski G; Lorenzen J; Grotelüschen R; Seitz U; Rogiers X; Adam G
    Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease.
    Tse CS; Loftus EV; Raffals LE; Gossard AA; Lightner AL
    Aliment Pharmacol Ther; 2018 Jul; 48(2):190-195. PubMed ID: 29808485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.
    Schmidt T; Schwinge D; Rolvien T; Jeschke A; Schmidt C; Neven M; Butscheidt S; Kriz M; Kunzmann L; Mussawy H; Hubert J; Hawellek T; Rüther W; Oheim R; Barvencik F; Lohse AW; Schramm C; Schinke T; Amling M
    J Hepatol; 2019 May; 70(5):941-953. PubMed ID: 30641095
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Primary sclerosing cholangitis: a twelve-year experience].
    Orellana I; Valera JM; Nei C; Poniachik J; Berger Z; Latorre R; Smok G; Brahm J
    Rev Med Chil; 2005 Jul; 133(7):776-80. PubMed ID: 16341383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary sclerosing cholangitis: a clinical case.
    Gubergrits NB
    Dig Dis; 2009; 27(4):522-5. PubMed ID: 19897969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fully automated detection of primary sclerosing cholangitis (PSC)-compatible bile duct changes based on 3D magnetic resonance cholangiopancreatography using machine learning.
    Ringe KI; Vo Chieu VD; Wacker F; Lenzen H; Manns MP; Hundt C; Schmidt B; Winther HB
    Eur Radiol; 2021 Apr; 31(4):2482-2489. PubMed ID: 32974688
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.
    Milkiewicz M; Klak M; Kempinska-Podhorodecka A; Wiechowska-Kozlowska A; Urasinska E; Blatkiewicz M; Wunsch E; Elias E; Milkiewicz P
    Sci Rep; 2016 Dec; 6():39573. PubMed ID: 28008998
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Native liver histology after successful portoenterostomy in biliary atresia.
    Lampela H; Kosola S; Heikkilä P; Lohi J; Jalanko H; Pakarinen MP
    J Clin Gastroenterol; 2014 Sep; 48(8):721-8. PubMed ID: 24275708
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.
    Gawrieh S; Sethunath D; Cummings OW; Kleiner DE; Vuppalanchi R; Chalasani N; Tuceryan M
    Ann Diagn Pathol; 2020 Aug; 47():151518. PubMed ID: 32531442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.